Understand · Discuss · Plan together
Genetic Testing of Children, Family Planning and Reproductive Options
The key question for a child is whether knowing the result changes care during childhood.
Chapter 15 of 16
Explore all 16 chapters
Adult-onset susceptibility
Predictive testing of an asymptomatic child for adult-onset BRCA-related risk is generally deferred until they can decide as an adult. Testing only to relieve an adult’s anxiety is not usually sufficient justification. Childhood testing for typical heterozygous Lynch syndrome is also generally deferred unless an unusual family pattern or clinical circumstance makes earlier management relevant.
When childhood testing can help
FAP, RET-related MEN2, RB1-related retinoblastoma, TP53-related disease and some other syndromes can need childhood action. Refer to paediatric genetics rather than applying a blanket “never test children” rule. Parents provide permission and the child should be involved according to maturity. Diagnostic testing for a symptomatic child is a separate question from predictive testing of a healthy child.
Inheritance and reproductive counselling
For many dominant syndromes a carrier has a 1-in-2 transmission chance in each pregnancy; cancer itself is not inherited with certainty. Recessive conditions require a different explanation and may justify partner testing. For example, two harmful variants in certain DNA-repair genes can cause serious childhood conditions. The genetics team should assess the actual family, not make assumptions from the surname or community.
Options, without pressure
Options may include natural conception with or without prenatal diagnosis, IVF with preimplantation genetic testing for a monogenic condition (PGT-M), donor eggs or sperm, adoption, or choosing not to have children. Availability, costs and eligibility must be discussed with an accredited local service. These choices are personal; no option is morally required by a genetic result.
What PGT-M can and cannot do
PGT-M usually requires a well-defined familial variant and a customised laboratory process. It is different from embryo chromosome screening (PGT-A), does not guarantee pregnancy or a child free of all health problems, and has residual error risk. Counselling should discuss confirmatory prenatal diagnosis, IVF burdens, and alternatives before treatment starts.
Sources and further reading
- NCI PDQ — Cancer Genetics Risk Assessment and Counseling
- ASRM — Preimplantation genetic testing for monogenic conditions (2023)
Accessible sources checked: 19 October 2026. International recommendations are identified where used; care in India requires individual clinical assessment. No claim is made to have directly verified restricted NCCN guidance.